财报披露
免疫子制药(IMRN)07-03 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058780 Act: 34 Size: 297 KB 网页链接
简介:Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司,拥有一个专利技术平台,专注于开发和商业化一类新型的特异性靶向多克隆抗体,公司相信这种抗体能够解决严重的未满足医疗需求。
今开:2.09 | 昨收:2.161 |
最高:2.1982 | 最低:1.9607 |
涨停价: | 跌停价: |
总市值:11503815 |
免疫子制药(IMRN)07-03 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058780 Act: 34 Size: 297 KB 网页链接
免疫子制药(IMRN)04-23 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-035096 Act: 34 Size: 17 MB 网页链接
免疫子制药(IMRN)05-28 18:05
$免疫子制药(IMRN)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046748 Act: 34 Size: 17 MB 网页链接
免疫子制药(IMRN)05-31 20:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-048181 Act: 34 Size: 13 MB 网页链接
免疫子制药(IMRN)07-03 18:05
$免疫子制药(IMRN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058720 Act: 33 Size: 953 KB 网页链接
免疫子制药(IMRN)04-10 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-031717 Act: 34 Size: 63 KB 网页链接
免疫子制药(IMRN)04-15 20:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032740 Act: 34 Size: 64 KB 网页链接
免疫子制药(IMRN)06-05 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-049849 Act: 34 Size: 52 KB 网页链接
免疫子制药(IMRN)05-03 20:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-039317 Act: 34 Size: 76 KB 网页链接
免疫子制药(IMRN)07-02 19:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058180 Act: 34 Size: 167 KB 网页链接
菠菜少女2020-07-21 04:13
$Immuron(IMRN)$ 今天我真的是成也它,败也它了查看全文
LaughingBoyGood2020-07-20 20:15
A-Simon2020-06-20 04:00
A-Simon2020-06-20 03:38
$Immuron(IMRN)$ 刚刚在忙没跑,收盘前20分钟会有什么变化吗……查看全文
A-Simon2020-06-20 00:50
$Immuron(IMRN)$ 再等一小时,没动静就跑了查看全文
A-Simon2020-06-19 22:28
$Immuron(IMRN)$ 冷静一下,站稳再冲一波吧查看全文
A-Simon2020-06-19 21:41
$Immuron(IMRN)$ 应该是熔断了查看全文
梅钞疯-价值微积分2020-06-19 21:37
$Immuron(IMRN)$ 向上熔断了查看全文
A-Simon2020-06-19 21:21
$Immuron(IMRN)$ 起飞吧!希望突破之前高点查看全文
Ffffffrrrr2020-06-19 19:53
$Immuron(IMRN)$ 11.5入,赌一把查看全文
格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助,这一举措是为了研究口服免疫疗法的给药方案,以供美国军队使用。Immuron是一家处于临床阶段的医疗公司,专注于一种新型特异性... 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058780 Act: 34 Size: 297 KB 网页链接
$免疫子制药(IMRN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058720 Act: 33 Size: 953 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058180 Act: 34 Size: 167 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-049849 Act: 34 Size: 52 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-048181 Act: 34 Size: 13 MB 网页链接
$免疫子制药(IMRN)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046748 Act: 34 Size: 17 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-039317 Act: 34 Size: 76 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-035096 Act: 34 Size: 17 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032740 Act: 34 Size: 64 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-031717 Act: 34 Size: 63 KB 网页链接